Hosagowdar S, Kinkar MG. PHARMACOVIGILANCE AND ADVERSE EVENT REPORTING IN CLINICAL TRIALS: BEST PRACTICES. EJMMP [Internet]. 2023 Oct. 25 [cited 2024 Nov. 15];3(10):18-27. Available from: http://inovatus.es/index.php/ejmmp/article/view/2009